Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Diabetes Mellitus × dapagliflozin × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Diabetes Mellitus, Type 2 1 Diabetes Mellitus 1

Interventions

saxagliptin 1 dapagliflozin 1 Metformin 1 Folic Acid 1 Fatty Acids, Omega-3 1 Desvenlafaxine Succinate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07033585 2025-07-11

GD-T2D

Medicine Invention Design, Inc

Phase 2/3 Active not recruiting

Diabetes Mellitus, Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡